Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
| Price | $10.82 |
|---|---|
| Market cap | $262.55M |
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
| 52-week range | 10.26-10.855 |
| Beta | 0 |
Explore DMAA's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.